Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Equity (Details)

v3.21.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Equity (Details) - USD ($)
3 Months Ended 8 Months Ended
Jul. 01, 2021
Sep. 30, 2021
Jun. 30, 2021
Sep. 30, 2021
Jun. 11, 2021
Mar. 31, 2021
Feb. 11, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Accretion for Class A common stock to redemption value   $ (1,897,313) $ (13,012,367) $ 14,909,680      
Total Stockholders' Equity (Deficit)   $ (11,104,394) (13,976,480) (11,104,394) $ (13,278,799) $ 24,000 $ 0
Proceeds received in excess of fair value of 5,250,000 Private Placement Warrants, net of offering costs       $ 5,700,000      
Private Placement Warrants              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Proceeds received in excess of fair value of 5,250,000 Private Placement Warrants, net of offering costs     $ 5,250,000        
Over-allotment option              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Sale of 15,000,000 Units, net of underwriting discounts (in shares) 2,250,000   15,000,000        
As previously reported | Restatement of redeemable common stock as temporary equity              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Sale of 15,000,000 Units, net of underwriting discounts     $ 136,800,951        
Proceeds received in excess of fair value of 5,250,000 Private Placement Warrants, net of offering costs     186,682        
Initial value of common stock subject to possible redemption at IPO date     (131,721,200)        
Change in value of common stock subject to redemption     697,690        
Total Stockholders' Equity (Deficit)     5,000,010   5,000,001    
Adjustment | Restatement of redeemable common stock as temporary equity              
Error Corrections and Prior Period Adjustments Restatement [Line Items]              
Sale of 15,000,000 Units, net of underwriting discounts     (136,800,951)        
Proceeds received in excess of fair value of 5,250,000 Private Placement Warrants, net of offering costs     (186,682)        
Initial value of common stock subject to possible redemption at IPO date     131,721,200        
Change in value of common stock subject to redemption     (697,690)        
Accretion for Class A common stock to redemption value     (13,012,367)        
Total Stockholders' Equity (Deficit)     $ (18,976,490)   $ (18,278,800)